Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined interferon and ribavirin therapy

被引：0
|
作者：
Esmat, G.
El Makhzangy, H.
Males, S.
Gad, R.
Rekacewicz, C.
Ismail, S.
Abdel-Hamid, M.
Eldaly, M.
Fontanet, A.
Mohamed, M. K.
机构：
[1] Cairo Univ, Sch Med, Cairo, Egypt
[2] Inst Pasteur, Paris, France
[3] Ain Shams Univ, Cairo, Egypt
[4] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt
[5] Menia Univ, Fac Med, Minia, Egypt
[6] Natl Liver Inst, Menoufia, Egypt
来源：
LIVER INTERNATIONAL | 2006年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Prediction of treatment outcome in genotype 4 chronic hepatitis C patients during combined pegylated interferon alpha-2a and ribavirin therapy (ANRS 1211 trial)
    Esmat, G.
    ElMakhzangy, H.
    Males, S.
    Gad, R. R.
    Rekacewicz, C.
    Ismail, S. A.
    Abdel-Hamid, M.
    El-Daly, M.
    Pol, S.
    Fontanet, A.
    Mohamed, M. K.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S138 - S138
  • [2] OUTCOME OF COMBINED INTERFERON-RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C
    Khurram, M.
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (08): : 516 - 516
  • [3] Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C
    Wendling, J
    Descamps, V
    Grossin, M
    Marcellin, P
    Le Bozec, P
    Belaich, S
    Crickx, B
    [J]. ARCHIVES OF DERMATOLOGY, 2002, 138 (04) : 546 - 547
  • [4] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
  • [5] Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin
    Jain, K
    Lam, WC
    Waheeb, S
    Thai, Q
    Heathcote, J
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (10) : 1171 - 1173
  • [6] Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan
    Lai, MY
    [J]. INTERVIROLOGY, 2005, 49 (1-2) : 91 - 95
  • [7] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Oguz, Dilek
    Cicek, Bahattin
    Filik, Levent
    Odemis, Bulent
    Kilic, Mesut
    Altintas, Engin
    Zengin, Neslihan
    Altiparmak, Emin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (04) : 580 - 583
  • [8] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Dilek Oguz
    Bahattin Cicek
    Levent Filik
    Bulent Odemis
    Mesut Kilic
    Engin Altintas
    Neslihan Zengin
    Emin Altiparmak
    [J]. World Journal of Gastroenterology, 2005, (04) : 580 - 583
  • [9] Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy
    Kim, TH
    Kim, KA
    Lim, YS
    Gwak, GY
    Yoon, JH
    Kang, GH
    Lee, HS
    [J]. INTERVIROLOGY, 2005, 48 (04) : 230 - 238
  • [10] Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin for chronic hepatitis C
    Ogana, G
    Tocco, A
    Garrucciu, G
    Branca, B
    Azara, V
    Manzoni, NE
    Deplano, A
    Solinas, A
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (03) : 254 - 255
12345